TARS Return on Tangible Equity | TARSUS PHARMACEUTICALS, INC.

TARSUS PHARMACEUTICALS, INC. (TARS) Return on Tangible Equity

2026-06-30: Return Tang Equity -13.68%.
2026-03-31: Return Tang Equity -14.12%.
2025-12-31: Return Tang Equity -19.76%.
2025-09-30: Return Tang Equity -24.78%.

Complete source-backed return tang equity history.

Available history: 2018-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-13.68%
2026-03-31	-14.12%
2025-12-31	-19.76%
2025-09-30	-24.78%
2025-06-30	-28.33%
2025-03-31	-31.39%
2024-12-31	-53.45%
2024-09-30	-58.69%
2024-06-30	-60.37%
2024-03-31	-54.60%
2023-12-31	-70.37%
2023-09-30	-51.31%
2023-06-30	-61.57%
2023-03-31	-37.64%
2022-12-31	-32.19%
2022-09-30	-31.26%
2022-06-30	-25.52%
2022-03-31	-29.79%
2021-12-31	-8.29%
2021-09-30	-5.83%
2021-06-30	-2.54%
2021-03-31	-7.90%
2020-12-31	-16.15%
2020-09-30	93.99%
2020-06-30	66.15%
2020-03-31	61.33%
2019-12-31	77.75%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-19.76%
2024-12-31	-53.45%
2023-12-31	-70.37%
2022-12-31	-32.19%
2021-12-31	-8.29%
2020-12-31	-16.15%
2019-12-31	77.77%
2018-12-31	97.42%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Denali Therapeutics Inc. (DNLI)	United States	$3.274B	-8.04
Relay Therapeutics, Inc. (RLAY)	United States	$3.884B	-14.30
Beam Therapeutics Inc. (BEAM)	United States	$2.549B	-41.51
Greenland Mines Ltd (GRML)	United States	$2.362B
BIOCRYST PHARMACEUTICALS INC (BCRX)	United States	$2.175B	-6.63
ADMA BIOLOGICS, INC. (ADMA)	United States	$2.131B	11.16
Kodiak Sciences Inc. (KOD)	United States	$2.090B	-10.12
RECURSION PHARMACEUTICALS, INC. (RXRX)	United States	$2.080B	-3.78
Vericel Corp (VCEL)	United States	$2.011B	93.97
Adaptive Biotechnologies Corp (ADPT)	United States	$4.719B	-53.43